2. As of noon trading, Omnicare ( OCR) is down $0.46 (-1.2%) to $38.00 on average volume Thus far, 623,920 shares of Omnicare exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $37.97-$38.65 after having opened the day at $38.53 as compared to the previous trading day's close of $38.46.

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company operates in two segments, Long-Term Care Group and Specialty Care Group. Omnicare has a market cap of $3.9 billion and is part of the services sector. The company has a P/E ratio of 21.8, above the S&P 500 P/E ratio of 17.7. Shares are up 6.6% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Omnicare a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Omnicare Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Market Signals Change of Direction: Cramer's 'Mad Money' Recap (Monday 9/18/17)

Cramer: Irma and Harvey Busted the Algos

Shrug Off The Apple-FANG Bite: Cramer's 'Mad Money' Recap (Thur 9/14/17)

Here Comes the Carnage: Market Recon